Curve Therapeutics
Drug Discovery
- Website
- https://www.curvetx.com/
- Membership category
- Corporate
School of Chemistry, Building 30, University Road, Southampton, SO17 1BJ, United Kingdom
Curve Therapeutics at a glance
Small-molecule drug discovery platform based on functional library screening inside mammalian cells to identify first- and best-in-class therapeutics
About Curve Therapeutics
Curve’s mission is to transform the discovery of first-in-class small molecule therapeutics by broadening the landscape of disease targets that can be drugged. The company’s Microcycle® platform enables direct screening for biologically active hits inside mammalian cells and creates a toolkit for hit-to-lead programmes. Curve is deploying this innovative platform to build a pipeline of first-in-class small molecules to address high priority, therapeutically relevant cancer targets.
Curve’s proprietary platform is built on pioneering research by the Tavassoli lab and described in more than 30 peer-reviewed publications covering a wide range of protein-protein interactions over a 15-year period. The central components of the Microcycle screening platform are protected through international patents and patent applications and exclusively licensed to Curve.
